Generic Name and Formulations:
Formulated bovine type I collagen (2.6%); topical gel.
Taxus Cardium Pharmaceuticals Group
Indications for EXCELLAGEN:
Management of wounds including: partial and full- thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/graft, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears) and draining wounds.
Adults and Children:
See literature. Perform debridement or excision prior to application. Apply a thin layer directly to the entire wound surface and edges. May be occluded with non-adherent, gauze and foam dressings; change dressings and reevaluate weekly. If healing is incomplete, gel may be reapplied; max once weekly.
Control excessive exudate, excessive bleeding, acute swelling, and/or infection before starting treatment. Discontinue or remove if infections, chronic inflammation, allergic reaction, excessive redness, pain, swelling occur. Do not freeze or reuse syringes. Avoid exposure to high temperature.
Wound care device.
Local reactions (eg, infections, inflammation, swelling).
Kit—1 (4 pre-filled, single-use [0.5mL] syringes w. applicators)
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Treatment With Alemtuzumab May Frequently Induce Thyroid Dysfunction
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- NT-proBNP May Predict Cardiovascular Outcomes in Type 2 Diabetes
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally